Biotech Specialty Pharma

Provectus Pharmaceuticals

7327 Oak Ridge Hwy
Knoxville, TN 37931 USA
Phone
Fax
Click for website

Research Sector Biotech Specialty Pharma

Summary Description Drug that selectively targets and destroys cancer cells without harming surrounding healthy tissue

Management Craig Dees Ph.D., Chief Executive Officer; Timothy Scott Ph.D., President; Eric Wachter Ph.D., Executive Vice President; Peter R. Culpepper CPA, MBA, Chief Financial Officer, Chief Operating Officer

Click here for Financial Data
Keywords: chemoablation, metastatic, melanoma, intralesional, rose bengal, oncology, cancer

Comment


Updated: Dec. 19, 2014


Description

Provectus Pharmaceuticals specializes in developing oncology and dermatology therapies. Its novel oncology drug PV-10 is designed to selectively target and destroy cancer cells without harming surroun......view more

Products / Services

Metastatic Melanoma (PV-10); Atopic Dermatitis (PH-10); Psoriasis (PH-10); Breast Cancer (PV-10); Liver Cancer (PV-10)......view more

Status

- Held end-of-Phase 2 meeting and discussion about the design of a pivotal Phase 3 randomized control study of PV-10 with the FDA - End-of-Phase 2 meeting was held with the Australian Therapeutic...view more

Analyst Coverage